Selective Rho Kinase Inhibitor Allows for Expansion of Human Primary Sebocytes In Vitro

J Invest Dermatol. 2016 Jun;136(6):1278-1280. doi: 10.1016/j.jid.2016.02.019. Epub 2016 Mar 2.

Authors

Amanda M Nelson¹, Melanie C Dispenza², Zhaoyuan Cong², Matthew Moll², Kathryn L Gilliland², Diane M Thiboutot³

Affiliations

¹ Department of Dermatology, Penn State Hershey College of Medicine, Hershey, PA, USA. Electronic address: anelson@hmc.psu.edu.
² Department of Dermatology, Penn State Hershey College of Medicine, Hershey, PA, USA.
³ Department of Dermatology, Penn State Hershey College of Medicine, Hershey, PA, USA. Electronic address: dthiboutot@hmc.psu.edu.

PMID: 26934599
DOI: 10.1016/j.jid.2016.02.019

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Amides / pharmacology*
Cell Proliferation / drug effects
Humans
Pyridines / pharmacology*
Sebaceous Glands / cytology*
rho-Associated Kinases / antagonists & inhibitors*

Substances

Amides
Pyridines
Y 27632
rho-Associated Kinases